Arbutus Biopharma Corp Quarterly Interest Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arbutus Biopharma Corp quarterly/annual Interest Expense history and growth rate from Q1 2016 to Q2 2024.
  • Arbutus Biopharma Corp Interest Expense for the quarter ending June 30, 2024 was $34K, a 80.1% decline year-over-year.
  • Arbutus Biopharma Corp Interest Expense for the twelve months ending June 30, 2024 was $168K, a 84.8% decline year-over-year.
  • Arbutus Biopharma Corp annual Interest Expense for 2023 was $459K, a 73.4% decline from 2022.
  • Arbutus Biopharma Corp annual Interest Expense for 2022 was $1.73M, a 39.6% decline from 2021.
  • Arbutus Biopharma Corp annual Interest Expense for 2021 was $2.86M, a 28.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $168K $34K -$137K -80.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $305K $44K -$154K -77.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $459K $44K -$265K -85.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $724K $46K -$383K -89.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $1.11M $171K -$311K -64.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.42M $198K -$308K -60.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.73M $309K -$251K -44.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $1.98M $429K -$333K -43.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.31M $482K -$281K -36.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $2.59M $506K -$266K -34.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.86M $560K -$237K -29.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.09M $762K -$312K -29.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $3.41M $763K -$336K -30.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.74M $772K -$269K -25.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $4.01M $797K -$197K -19.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $4.21M $1.07M -$26K -2.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $4.23M $1.1M +$1.1M +54850% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $3.14M $1.04M +$1.03M +8575% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $2.11M $994K +$872K +715% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $1.24M $1.1M +$1.1M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $136K $2K +$2K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $134K $12K -$92K -88.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $226K $122K +$47K +62.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $179K $0 -$76K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $255K $0 -$68K -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $323K $104K +$62K +148% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $261K $75K +$75K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 $186K $76K +$76K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $110K $68K +$68K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $42K $42K +$42K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $0 $0 Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.